BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Xiao Y, Li Q, Yao J, Yuan X, Zhang Y, Yin X, Saito Y, Fan H, Li P, Kuo WL, Halpin A, Gibbons DL, Yagita H, Zhao Z, Pang D, Ren G, Yee C, Lee JJ, Yu D. The allergy mediator histamine confers resistanceto immunotherapy in cancer patients via activationof the macrophage histamine receptor H1. Cancer Cell 2021:S1535-6108(21)00602-4. [PMID: 34822775 DOI: 10.1016/j.ccell.2021.11.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Cully M. Antihistamines boost immunotherapy. Nat Rev Cancer 2021. [PMID: 34903891 DOI: 10.1038/s41568-021-00437-y] [Reference Citation Analysis]
2 Persico M, Abbruzzese C, Matteoni S, Matarrese P, Campana AM, Villani V, Pace A, Paggi MG. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma. Cells 2022;11:263. [DOI: 10.3390/cells11020263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wu M, Huang Q, Xie Y, Wu X, Ma H, Zhang Y, Xia Y. Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. J Hematol Oncol 2022;15:24. [PMID: 35279217 DOI: 10.1186/s13045-022-01242-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
4 Honda T, Keith YH. Novel Insights Into the Immune-Regulatory Functions of Mast Cells in the Cutaneous Immune Response. Front Immunol 2022;13:898419. [DOI: 10.3389/fimmu.2022.898419] [Reference Citation Analysis]
5 Pittet MJ, Michielin O, Migliorini D. Clinical relevance of tumour-associated macrophages. Nat Rev Clin Oncol 2022. [PMID: 35354979 DOI: 10.1038/s41571-022-00620-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Balcziak LK, Russo AF. Dural Immune Cells, CGRP, and Migraine. Front Neurol 2022;13:874193. [DOI: 10.3389/fneur.2022.874193] [Reference Citation Analysis]
7 Donnenberg VS, Wagner PL, Luketich JD, Bartlett DL, Donnenberg AD. Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity. Front Immunol 2022;13:846235. [DOI: 10.3389/fimmu.2022.846235] [Reference Citation Analysis]
8 Bai Z, Ai J, Wei X. Histamine and histamine receptor H1 (HRH1) axis: new target for enhancing immunotherapy response. Mol Biomed 2022;3:11. [PMID: 35378699 DOI: 10.1186/s43556-022-00073-4] [Reference Citation Analysis]
9 Howard F, Conner J, Danson S, Muthana M. Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability. Front Mol Biosci 2022;9:889395. [DOI: 10.3389/fmolb.2022.889395] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Segura-villalobos D, Lamas M, González-espinosa C. Cyclic Hypoxia Induces Transcriptomic Changes in Mast Cells Leading to a Hyperresponsive Phenotype after FcεRI Cross-Linking. Cells 2022;11:2239. [DOI: 10.3390/cells11142239] [Reference Citation Analysis]
11 Lorentz A, Bilotta S, Civelek M. Molecular links between allergy and cancer. Trends in Molecular Medicine 2022. [DOI: 10.1016/j.molmed.2022.06.003] [Reference Citation Analysis]
12 Bergmann C, Poli A, Agache I, Bianchini R, Bax HJ, Castells M, Crescioli S, Dombrowicz D, Ferastraoaru D, Fiebiger E, Gould HJ, Hartmann K, Izquierdo E, Jordakieva G, Josephs DH, Jutel M, Levi-Schaffer F, de Las Vecillas L, Lotze MT, Osborn G, Pascal M, Redegeld F, Rosenstreich D, Roth-Walter F, Schmidt-Weber C, Shamji M, Steveling EH, Turner MC, Untersmayr E, Jensen-Jarolim E, Karagiannis SN. AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper. Allergy 2022. [PMID: 35152450 DOI: 10.1111/all.15255] [Reference Citation Analysis]
13 Wang T, Xu H. Multi-faced roles of reactive oxygen species in anti-tumor T cell immune responses and combination immunotherapy. Exploration of Medicine. [DOI: 10.37349/emed.2022.00076] [Reference Citation Analysis]
14 Bordon Y. Antitumour roles for antihistamines. Nat Rev Immunol 2021. [PMID: 34880394 DOI: 10.1038/s41577-021-00670-4] [Reference Citation Analysis]
15 Cully M. Anti-histamines boost immunotherapy. Nat Rev Drug Discov 2021. [PMID: 34862488 DOI: 10.1038/d41573-021-00204-6] [Reference Citation Analysis]
16 Nathan C. Nonresolving inflammation redux. Immunity 2022;55:592-605. [PMID: 35417674 DOI: 10.1016/j.immuni.2022.03.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]